Belgian experience with direct acting antivirals in people who inject drugs
Abstract
PWID, especially active users, are underserved for DAA treatment in real life in Belgium. Reimbursement criteria based on fibrosis stage make it difficult to treat PWID. Treatment adherence is similar in PWID and the general population, even in patients with active abuse. DAA were safe and effective …
Keywords
National Center for Biotechnology Information
NCBI
NLM
MEDLINE
humans
pubmed abstract
nih
national institutes of health
national library of medicine
adult
female
male
aged
middle aged
Retrospective Studies
Cohort Studies
substance abuse
hepatitis c / epidemiology*
antiviral agents / therapeutic use*
antiviral agents / pharmacology
intravenous / epidemiology*
pmid:28618285
doi:10.1016/j.drugalcdep.2017.04.003
rob bielen
christophe moreno
geert robaeys
belgium / epidemiology
hepacivirus / drug effects
hepatitis c / drug therapy*
imidazoles / pharmacology
imidazoles / therapeutic use
simeprevir / pharmacology
simeprevir / therapeutic use
sofosbuvir / pharmacology
sofosbuvir / therapeutic use
intravenous / drug therapy*
Access
Citation
ID:
266044
References
Blockchain Verification
Account:
NFT Contract Address:
0x95644003c57E6F55A65596E3D9Eac6813e3566dA
Article ID:
266044
Unique Identifier:
Network:
Scimatic Chain (ID: 481)
Loading...
Blockchain Readiness Checklist
Authors
Abstract
Journal Name
Year
Title
Creates 1,000,000 NFT tokens for this article
Token Features:
- ERC-1155 Standard NFT
- 1 Million Supply per Article
- Transferable via MetaMask
- Permanent Blockchain Record
Scan with Saymatik Web3.0 Wallet
